The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).
Jul 12, 2024
0
1
The road leading to a career in pediatrics is becoming more deserted these days, and the decline in subspecialty interest has led to significant concerns regarding the ability of health care professionals to meet the growing ...
Jul 4, 2024
0
31
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published in JAMA Network Open by leaders from Nemours Children's Health and Endeavor ...
Jul 3, 2024
0
4
Researchers in the Division of Orthopedics and Sports Medicine and Performance Center at Children's Hospital of Philadelphia (CHOP) announced results from a large retrospective study of patients surgically treated for patellar ...
Jul 2, 2024
0
0
Analyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect children from the worst effects of COVID-19 ...
Jul 1, 2024
0
26
In a policy statement issued by the American Academy of Pediatrics and published online June 27 in Pediatrics, recommendations are presented for optimizing advanced imaging use for pediatric patients in the emergency department.
Jun 28, 2024
0
0
In a landmark study, researchers from Children's Hospital of Philadelphia (CHOP) found that two separate objective assessment tools and nonverbal measurements of IQ can help assess cognitive function in children with Aicardi ...
Jun 25, 2024
0
1
The U.S. Food and Drug Administration has expanded indications for AbbVie's Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic ...
Jun 24, 2024
0
0
Recent advances in genomic sequencing have revealed that 5–15% of children with cancer have an underlying genetic predisposition. Although genetic predispositions increase the risk for new tumors, it has been unclear when ...
Jun 21, 2024
0
19
The U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally ...
Jun 21, 2024
0
0
